Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fengwei Tan

Showing results (111-120 of 151) with videos related to

Pageof 16
Sort By:
The Lancet. Oncology|August 15, 2021
Treatment-related adverse events of PD-1 and PD-L1 inhibitor-based combination therapies in clinical trials: a systematic review and meta-analysisXiaoxiang Zhou, Zhuoran Yao, Hua Bai, et al.
Cancer Cell International|December 21, 2021
An immune-related lncRNA signature predicts prognosis and adjuvant chemotherapeutic response in patients with small-cell lung cancerZhihui Zhang, Yuejun Luo, Chaoqi Zhang, et al.
Cancer Innovation|January 22, 2026
Global, Population and Genetic Evidence on the Relationships Between Immune-Mediated Inflammatory Disease and Cancer RiskXuesi Dong, Jiaxin Xie, Zilin Luo, et al.
Journal of the National Cancer Center|April 20, 2026
Long-term outcomes and clinical features of stage III non-small-cell lung cancer harboring ALK rearrangements: a multicenter retrospective study of 176 patientsFengwei Tan, Ying Jiang, Jianchun Duan, et al.
Frontiers in Oncology|May 26, 2022
RNA Sequencing of Tumor-Educated Platelets Reveals a Three-Gene Diagnostic Signature in Esophageal Squamous Cell CarcinomaTiejun Liu, Xin Wang, Wei Guo, et al.
Cancer Communications (London, England)|June 22, 2022
Gene amplification-driven RNA methyltransferase KIAA1429 promotes tumorigenesis by regulating BTG2 via m6A-YTHDF2-dependent in lung adenocarcinomaChang Zhang, Qi Sun, Xu Zhang, et al.
The Annals of Thoracic Surgery|April 27, 2019
Tracheobronchial Adenoid Cystic Carcinoma: 50-Year Experience at the National Cancer Center, ChinaYalong Wang, Songhua Cai, Shugeng Gao, et al.
Chest|January 22, 2024
Risk-Adapted Starting Age of Personalized Lung Cancer Screening: A Population-Based, Prospective Cohort Study in ChinaChenran Wang, Xuesi Dong, Fengwei Tan, et al.
Journal of Advanced Research|April 3, 2025
Lipidomic signatures as predictive biomarkers for early-onset lung cancer: Identification and development of a risk prediction modelFei Wang, Zeming Guo, Wei Tang, et al.
Cancer Medicine|April 8, 2020
Risk prediction model for lung cancer incorporating metabolic markers: Development and internal validation in a Chinese populationZhangyan Lyu, Ni Li, Shuohua Chen, et al.
Pageof 16

Showing results (111-120 of 151) with videos related to

Sort By:
Pageof 16
The Lancet. Oncology|August 15, 2021
Treatment-related adverse events of PD-1 and PD-L1 inhibitor-based combination therapies in clinical trials: a systematic review and meta-analysisXiaoxiang Zhou, Zhuoran Yao, Hua Bai, et al.
Cancer Cell International|December 21, 2021
An immune-related lncRNA signature predicts prognosis and adjuvant chemotherapeutic response in patients with small-cell lung cancerZhihui Zhang, Yuejun Luo, Chaoqi Zhang, et al.
Cancer Innovation|January 22, 2026
Global, Population and Genetic Evidence on the Relationships Between Immune-Mediated Inflammatory Disease and Cancer RiskXuesi Dong, Jiaxin Xie, Zilin Luo, et al.
Journal of the National Cancer Center|April 20, 2026
Long-term outcomes and clinical features of stage III non-small-cell lung cancer harboring ALK rearrangements: a multicenter retrospective study of 176 patientsFengwei Tan, Ying Jiang, Jianchun Duan, et al.
Frontiers in Oncology|May 26, 2022
RNA Sequencing of Tumor-Educated Platelets Reveals a Three-Gene Diagnostic Signature in Esophageal Squamous Cell CarcinomaTiejun Liu, Xin Wang, Wei Guo, et al.
Cancer Communications (London, England)|June 22, 2022
Gene amplification-driven RNA methyltransferase KIAA1429 promotes tumorigenesis by regulating BTG2 via m6A-YTHDF2-dependent in lung adenocarcinomaChang Zhang, Qi Sun, Xu Zhang, et al.
The Annals of Thoracic Surgery|April 27, 2019
Tracheobronchial Adenoid Cystic Carcinoma: 50-Year Experience at the National Cancer Center, ChinaYalong Wang, Songhua Cai, Shugeng Gao, et al.
Chest|January 22, 2024
Risk-Adapted Starting Age of Personalized Lung Cancer Screening: A Population-Based, Prospective Cohort Study in ChinaChenran Wang, Xuesi Dong, Fengwei Tan, et al.
Journal of Advanced Research|April 3, 2025
Lipidomic signatures as predictive biomarkers for early-onset lung cancer: Identification and development of a risk prediction modelFei Wang, Zeming Guo, Wei Tang, et al.
Cancer Medicine|April 8, 2020
Risk prediction model for lung cancer incorporating metabolic markers: Development and internal validation in a Chinese populationZhangyan Lyu, Ni Li, Shuohua Chen, et al.
Pageof 16